Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Cancer Biology & Therapy
|
November 4, 2015
Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
Wenxiu Qi, Wenbo Zhang, Holly Edwards, et al.
Journal of Cellular and Molecular Medicine
|
May 28, 2020
CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
Cheng Hu, Hongyan Xia, Shanshan Bai, et al.
Blood
|
July 30, 2009
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia
Holly Edwards, Chengzhi Xie, Katherine M LaFiura, et al.
Journal of the National Cancer Institute
|
February 3, 2005
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia
Yubin Ge, Mark L Stout, Dana A Tatman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells
Mingjun Liu, Yubin Ge, Scott G Payton, et al.
Blood
|
August 20, 2004
Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome
Jeffrey W Taub, Gina Mundschau, Yubin Ge, et al.
Biochemical Pharmacology
|
February 19, 2024
Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax
Jianlei Zhao, Shuangshuang Wu, Deying Wang, et al.
Plos One
|
November 19, 2013
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51
Chengzhi Xie, Christina Drenberg, Holly Edwards, et al.
Plos One
|
December 20, 2012
Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer
Guan Wang, Jing He, Jianyun Zhao, et al.
Plos One
|
August 19, 2016
Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia
Holly Edwards, Mara Rubenstein, Alan A Dombkowski, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Cancer Biology & Therapy
|
November 4, 2015
Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
Wenxiu Qi, Wenbo Zhang, Holly Edwards, et al.
Journal of Cellular and Molecular Medicine
|
May 28, 2020
CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
Cheng Hu, Hongyan Xia, Shanshan Bai, et al.
Blood
|
July 30, 2009
RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia
Holly Edwards, Chengzhi Xie, Katherine M LaFiura, et al.
Journal of the National Cancer Institute
|
February 3, 2005
GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia
Yubin Ge, Mark L Stout, Dana A Tatman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells
Mingjun Liu, Yubin Ge, Scott G Payton, et al.
Blood
|
August 20, 2004
Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome
Jeffrey W Taub, Gina Mundschau, Yubin Ge, et al.
Biochemical Pharmacology
|
February 19, 2024
Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax
Jianlei Zhao, Shuangshuang Wu, Deying Wang, et al.
Plos One
|
November 19, 2013
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51
Chengzhi Xie, Christina Drenberg, Holly Edwards, et al.
Plos One
|
December 20, 2012
Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer
Guan Wang, Jing He, Jianyun Zhao, et al.
Plos One
|
August 19, 2016
Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia
Holly Edwards, Mara Rubenstein, Alan A Dombkowski, et al.
Page
of 14